PulseAugur
中
实时 01:01:41
实体 Lifang Pharmaceutical

Lifang Pharmaceutical

PulseAugur coverage of Lifang Pharmaceutical — every cluster mentioning Lifang Pharmaceutical across labs, papers, and developer communities, ranked by signal.

Show in brief
总计 · 30天
1
90 天内 1
发布 · 30天
0
90 天内 0
论文 · 30天
0
90 天内 0
层级分布 · 90 天
时间线
  1. 2026-05-22 product_launch Lifang Pharmaceutical received approval for its Azilsartan Medoxomil Potassium tablets. 来源
情绪 · 30 天

1 天有情绪数据

最近 · 第 1/1 页 · 共 1 条
  1. TOOL · CL_43892 ·

    Lifang Pharmaceutical secures approval for hypertension drug

    Lifang Pharmaceutical has received approval from China's National Medical Products Administration for its Azilsartan Medoxomil Potassium tablets, indicated for treating adult primary hypertension. This marks a significa…